15th Anniversary of Pharmaceutics—Improvement of Drug Bioavailability
2024
Improvement of Drug Bioavailability
Editorial
Author Information
Author(s): Vandamme Thierry F.
Primary Institution: Centre de Recherche en Biomédecine de Strasbourg (CRBS), University of Strasbourg
Conclusion
The future of improving drug bioavailability will be shaped by a multidisciplinary approach, combining biotechnology, materials science, personalized medicine, and AI.
Supporting Evidence
- Improving drug bioavailability can lead to lower doses and fewer side effects.
- Better bioavailability can make drugs more effective and safer for patients.
- Research in bioavailability enhancement provides pharmaceutical companies with more tools to develop effective treatments.
Takeaway
This article talks about how making drugs work better in our bodies can help people get better treatment with fewer side effects. It also mentions new ways to deliver medicine that could make it easier for patients to take their medicine.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website